Public attention focused on early detection and strategies to prevent breast cancer.

A new blood-based genetic test might predict the presence of dangerous BRCA1 or BRCA2 gene mutations in women, according to a study published in the January 22 issue of Cancer Prevention Research.

Atossa Genetics develops noninvasive method of nipple aspirate fluid collection for cytological testing.